Outlook Sets Out Plans For Ophthalmic Bevacizumab In Europe

As Formal European Approval Arrives For Lytenava, Firm Sets Launch Date

 
• By David Wallace
EU flag reflected in eye
Outlook has received approval for its Lytenava ophthalmic bevacizumab • Source: Shutterstock

More from Products

More from Generics Bulletin